Imatinib mesylate (Glivec) as a treatment for gastrointestinal stromal tumor (Gist) - Long term follow-up

Eliyahu Raccah*, Ofer Merimsky, Abraham Kuten, Sara Apter, Raphael Catane

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Imatinib mesylate (Glivec) as a treatment for gastrointestinal stromal tumor (Gist) - Long term follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences